BIFIDO Co., Ltd. (KOSDAQ:238200)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,020.00
-50.00 (-1.63%)
At close: Jan 23, 2026
-5.48%
Market Cap24.70B
Revenue (ttm)18.65B
Net Income (ttm)-246.68M
Shares Out8.18M
EPS (ttm)-30.17
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume35,965
Average Volume13,196
Open3,060.00
Previous Close3,070.00
Day's Range2,910.00 - 3,065.00
52-Week Range2,895.00 - 4,390.00
Beta1.15
RSI34.70
Earnings DateMar 13, 2026

About BIFIDO

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1999
Employees 83
Stock Exchange KOSDAQ
Ticker Symbol 238200
Full Company Profile

Financial Performance

Financial Statements